About CeGaT
CeGaT is a company based in Tubingen (Germany) founded in 2002. The company has 113 employees as of December 31, 2020. CeGaT offers products and services including Exome Diagnostics, Prenatal ExomeXtra, Panel Diagnostics, and CancerPrecision. CeGaT operates in a competitive market with competitors including Eurofins Scientific, WuXi AppTec, Omniome, Ipsen and Tessera Therapeutics, among others.
- Headquarter Tubingen, Germany
- Employees 113 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Cegat Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$108.6 K (USD), Grant
Jan 01, 2016
- Investors
-
Employee Count
113
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CeGaT
CeGaT offers a comprehensive portfolio of products and services, including Exome Diagnostics, Prenatal ExomeXtra, Panel Diagnostics, and CancerPrecision.
Service for detecting genetic variants in rare diseases
Sequencing tool for prenatal genetic analysis
Targeted sequencing for specific disease panels
Tool for precise tumor genetic analysis
People of CeGaT
Unlock access to complete
Funding Insights of CeGaT
Investors in CeGaT
CeGaT has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for CeGaT
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CeGaT
Investment portfolio details for CeGaT
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CeGaT
Detailed financials for CeGaT
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cegat Comparisons
Peer comparison for CeGaT
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CeGaT
CeGaT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, WuXi AppTec, Omniome, Ipsen and Tessera Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Laboratory testing and contract research services are provided globally.
|
|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| Locked | Locked | Locked |
New genome engineering technology is provided for treating multiple diseases.
|
|
| Locked | Locked | Locked |
DNA-encoded libraries are developed for drug discovery applications.
|
Detailed competitors of CeGaT
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cegat
Complete news archive for CeGaT
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CeGaT
CeGaT was founded in 2002 and raised its 1st funding round 14 years after it was founded.
CeGaT is headquartered in Tubingen, Germany. It is registered at Tubingen, Baden-wurttemberg, Germany.
As of Dec 31, 2020, the latest employee count at CeGaT is 113.
CeGaT, founded in 2002 in Tubingen, Germany, focuses on providing healthcare solutions, biopharma outsourcing, and diversified. Provider of drug research and development services to develop genetic causes of rare diseases. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
CeGaT's top competitors include Tessera Therapeutics, Novogene Corporation and WuXi AppTec.
CeGaT offers Exome Diagnostics, Prenatal ExomeXtra, Panel Diagnostics, and CancerPrecision.
CeGaT has 1 investor. Key investors include European Union.